
Amphastar Pharmaceuticals, Inc.
AMPHNasdaqCIK 1297184HealthcareFiscal year ends Dec 31
Reports and events: 172 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2020-03-1216:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-20-000003 |
| 2019-11-0817:06 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001297184-19-000044 |
| 2019-11-0716:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-19-000041 |
| 2019-08-0919:11 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001297184-19-000038 |
| 2019-08-0716:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-19-000033 |
| 2019-06-1921:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001297184-19-000030 |
| 2019-06-1306:38 ET | 8-K | 5.07 Shareholder vote results | 0001558370-19-005662 |
| 2019-05-1019:34 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001297184-19-000027 |
| 2019-05-0916:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-19-000024 |
| 2019-04-1816:11 ET | DEF 14A | Proxy statementPeriod 2019-06-12 | 0001297184-19-000019 |
| 2019-03-1520:42 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001297184-19-000013 |
| 2019-03-1416:58 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001297184-19-000009 |
| 2019-03-1216:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-19-000003 |
| 2018-11-0919:38 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001297184-18-000050 |
| 2018-11-0816:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-18-000046 |
| 2018-11-0806:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-18-008890 |
| 2018-08-0918:40 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001297184-18-000043 |
| 2018-08-0816:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-18-000041 |
| 2018-07-0916:09 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001297184-18-000036 |
| 2018-06-0820:33 ET | 8-K | 5.07 Shareholder vote results | 0001297184-18-000031 |
| 2018-05-1019:13 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001297184-18-000029 |
| 2018-05-0916:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-18-000027 |
| 2018-04-1816:09 ET | DEF 14A | Proxy statementPeriod 2018-06-07 | 0001297184-18-000020 |
| 2018-03-2106:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-18-002285 |
| 2018-03-1419:58 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001297184-18-000011 |
| 2018-03-1216:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-18-000007 |
| 2017-11-0920:27 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001297184-17-000035 |
| 2017-11-0816:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-17-000033 |
| 2017-08-0917:21 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001297184-17-000028 |
| 2017-08-0916:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-17-000026 |
| 2017-07-2406:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-17-005265 |
| 2017-06-0920:34 ET | 8-K | 5.07 Shareholder vote results | 0001297184-17-000020 |
| 2017-05-1017:59 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001558370-17-004032 |
| 2017-05-0816:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-17-000017 |
| 2017-04-2116:10 ET | DEF 14A | Proxy statementPeriod 2017-06-08 | 0001297184-17-000011 |
| 2017-03-1518:57 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001297184-17-000007 |
| 2017-03-1316:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-17-000003 |
| 2016-12-2706:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-16-010637 |
| 2016-11-1017:09 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events | 0001297184-16-000029 |
| 2016-11-0906:31 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001558370-16-009753 |
| 2016-11-0816:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-16-000024 |
| 2016-08-0906:07 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001558370-16-007706 |
| 2016-08-0816:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-16-000018 |
| 2016-08-0406:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-16-007297 |
| 2016-07-0716:18 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001297184-16-000014 |
| 2016-06-1016:12 ET | 8-K | 5.07 Shareholder vote results | 0001297184-16-000010 |
| 2016-05-1006:22 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001558370-16-005745 |
| 2016-05-0916:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001297184-16-000007 |
| 2016-04-2216:02 ET | DEF 14A | Proxy statementPeriod 2016-06-09 | 0001297184-16-000003 |
| 2016-03-1514:08 ET | 10-K | Annual reportPeriod 2015-12-31 | 0001558370-16-004146 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.